Literature DB >> 11168408

Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector.

C Devaux1, E Moreau, M Goyffon, H Rochat, P Billiald.   

Abstract

9C2 is a murine monoclonal IgG that participates in the neutralization of Androctonus australis hector scorpion venom. It recognizes AahI and AahIII, two of the three main neurotoxins responsible for almost all the toxicity of the venom when injected into mammals. Using PCR we cloned the antibody variable region coding genes from 9C2 hybridoma cells and constructed a gene encoding a single-chain antibody variable fragment molecule (scFv). This scFv was produced in the periplasm of Escherichia coli in a soluble and functional form and purified in a single step using protein L-agarose beads yielding 1-2 mg.L(-1) of bacterial culture. scFv9C2 was predominantly monomeric but also tended to form dimeric and oligomeric structures, all capable of binding toxin AahI. The affinity of scFv and the parental mAb for toxin AahI and homologous toxin AahIII was of the same magnitude, in the nanomolar range. Similarly, purified forms of scFv9C2 completely inhibited the binding of toxin AahI to rat brain synaptosomes. Finally, scFv9C2 was efficient in protecting mice against the toxic effects of AahI after injection of the toxin and scFv to mice by the intracerebroventricular route in a molar ratio as low as 0.36 : 1. Thus, we produced a recombinant scFv that reproduces the recognition properties of the parent antibody and neutralizes the scorpion neurotoxin AahI, thereby opening new prospects for the treatment of envenomation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168408     DOI: 10.1046/j.1432-1327.2001.01923.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

1.  Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom.

Authors:  Anne di Tommaso; Matthieu O Juste; Marie-France Martin-Eauclaire; Isabelle Dimier-Poisson; Philippe Billiald; Nicolas Aubrey
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

2.  Structural insights into antibody sequestering and neutralizing of Na+ channel α-type modulator from old world scorpion venom.

Authors:  Igor P Fabrichny; Grégoire Mondielli; Sandrine Conrod; Marie-France Martin-Eauclaire; Yves Bourne; Pascale Marchot
Journal:  J Biol Chem       Date:  2012-02-27       Impact factor: 5.157

3.  Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.

Authors:  H W Wang; D Cole; W Z Jiang; H T Jin; N Fu; Z L Chen; N Y Jin
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

4.  Effect of temperature on the production of a recombinant antivenom in fed-batch mode.

Authors:  Susana María Alonso Villela; Hazar Ghezal-Kraïem; Balkiss Bouhaouala-Zahar; Carine Bideaux; César Arturo Aceves Lara; Luc Fillaudeau
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-14       Impact factor: 4.813

5.  Exploiting cross-reactivity to neutralize two different scorpion venoms with one single chain antibody fragment.

Authors:  Lidia Riaño-Umbarila; Gabriel Contreras-Ferrat; Timoteo Olamendi-Portugal; Citlalli Morelos-Juárez; Gerardo Corzo; Lourival D Possani; Baltazar Becerril
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

6.  In vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH).

Authors:  Hamid Bakherad; Seyed Latif Mousavi Gargari; Iraj Rasooli; Masoumeh Rajabibazl; Mohammad Mohammadi; Walead Ebrahimizadeh; Leila Safaee Ardakani; Hamed Zare
Journal:  Mol Biotechnol       Date:  2013-10       Impact factor: 2.695

Review 7.  Botulinum neurotoxins and botulism: a novel therapeutic approach.

Authors:  Jeeraphong Thanongsaksrikul; Wanpen Chaicumpa
Journal:  Toxins (Basel)       Date:  2011-05-13       Impact factor: 4.546

Review 8.  Engineering venom's toxin-neutralizing antibody fragments and its therapeutic potential.

Authors:  Larissa M Alvarenga; Muhammad Zahid; Anne di Tommaso; Matthieu O Juste; Nicolas Aubrey; Philippe Billiald; Julien Muzard
Journal:  Toxins (Basel)       Date:  2014-08-21       Impact factor: 4.546

9.  A method to confer Protein L binding ability to any antibody fragment.

Authors:  Zineb Lakhrif; Martine Pugnière; Corinne Henriquet; Anne di Tommaso; Isabelle Dimier-Poisson; Philippe Billiald; Matthieu O Juste; Nicolas Aubrey
Journal:  MAbs       Date:  2015-12-18       Impact factor: 5.857

Review 10.  Biotechnological Trends in Spider and Scorpion Antivenom Development.

Authors:  Andreas Hougaard Laustsen; Mireia Solà; Emma Christine Jappe; Saioa Oscoz; Line Præst Lauridsen; Mikael Engmark
Journal:  Toxins (Basel)       Date:  2016-07-23       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.